Novartis To Buy US Pharma Biz Anthos For Up To $3.1B
By Najiyya Budaly · February 11, 2025, 11:20 AM GMT
Novartis AG said Tuesday that it plans to buy Anthos Therapeutics Inc. for up to $3.1 billion, allowing the Swiss pharmaceutical heavyweight to return a drug that originated at the company...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login